Home
Menu
Adare Pharma Solutions on LinkedInAdare Pharma Solutions on FacebookAdare Pharma Solutions on TwitterAdare Pharma Solutions on Glassdoor
Logo: Adare Pharma Solutions
  • Quick Links
    • Learn About Our Precision Particle Fabrication® Technology
    • Explore Careers at Adare Pharma Solutions
    • Read About Our Latest News & Events
    • Knowledge Center

Patient-Centric Solutions

  • Overview
  • Taste Masking
  • Customized Release
  • Bioavailability Enhancement

Microbiome

Newsroom

Events

Technologies

  • Overview
  • AdvaTab®
  • Diffucaps®
  • Diffutab®
  • Microcaps®
  • Minitabs™
  • Optimμm®
  • Orbexa™
  • Parvulet™
  • Stratμm®
  • Unisun®

Manufacturing

  • Overview

Development Services

  • Overview
  • Precision Particle Fabrication®

Quality & Regulatory

Knowledge Center

Blog

Customer-Focused Support

About Us

  • Our Legacy
  • Our Leadership
  • Our People

Careers

Contact Us

Medical Inquiries

Meet With Us

Upcoming Events

 
  • Latest News
    • 01-26-21 Adare Pharma Solutions Opens New Small-Scale Laboratory to Offer Faster and More Efficient Development Capabilities to Clients

      New laboratory brings customizable, flexible systems to expedite formulation and process development services Provides customers more early stage... Learn More

    • 09-22-20 THOMAS H. LEE PARTNERS AND FRAZIER HEALTHCARE PARTNERS ACQUIRE ADARE

      Boston, MA and Seattle, WA - September 22, 2020 Transaction includes specialty CDMO business, including pharmaceutical technology and microbiome... Learn More

    • 05-04-20 Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences

      Lawrenceville, NJ, and Lenexa, KS - May 4, 2020 Kansas-based pharmaceutical technology company develops customized formulations and intellectual... Learn More

    • 01-13-20 Adare Pharmaceuticals and NLS Pharmaceutics collaborate to develop mazindol controlled release (CR) for the treatment of ADHD and narcolepsy

      Lawrenceville, NJ & Switzerland - January 13, 2020 Adare Pharmaceuticals, Inc. (Adare) and NLS Pharmaceutics Ltd. (NLS) announced today a collaboration... Learn More

    • View all
  • Events
    • Mar 15-17

      2021 DDF Summit Berlin Digital

      Virtual Events | Virtual

      The 2021 Virtual Summit covers both small...

    • Mar 15-17

      2021 PDA Annual Meeting

      Virtual Events | Virtual

      This premier conference will offer a new format, new pricing, and new ways to connect! What will...

    • Mar 22-25

      2021 Bio Europe Spring Digital

      Virtual Events | Virtual

      This year's digital event, delivered March 22-25, will include on-demand early access to the...

    • Mar 23-24

      2021 Pharma Contract Manufacturing Virtual Summit

      Virtual Events | Virtual

      Join this engaging digital exchange of knowledge and relationship-building, in the absense of...

    • Apr 14-16

      CPhI Japan 2021

      Conferences | TBD

    • View all

Our global manufacturing sites meet all cGMP standards, and are optimized for the development and production of specialized oral-dose and injectable delivery systems. And through our in-house regulatory affairs team, Adare can take your product from molecule to market, quickly and efficiently.

— Giovanni Ortenzi, Pharmaceutical Development & Chief Technical Officer

Adare Pharma Solutions

CORPORATE OFFICES

Headquarters:
Princeton Pike Corporate Center
1200 Lenox Drive, Suite 100
Lawrenceville, NJ 08648
USA
+1 (609) 450-1312
597, Boul. Laurier
Mont-Saint-Hilaire, QC
Canada, J3H 6C4
+1 (450) 600-1414

MANUFACTURING

Via Martin Luther King, 13
20060 Pessano con Bornago (MI)
Italy
+39 02 954281
Via Molise, 16
20098 San Giuliano Milanese (MI)
Italy
+39 02 988981-200
Route de Bû
78550 Houdan
France
+33 (0)1 30 46 19 00

DEVELOPMENT & MANUFACTURING

845 Center Drive
Vandalia, Ohio 45377
USA
+1 (937) 898-9669
8006 Reeder Street
Lenexa, KS 66214
USA

©2021 Adare Pharma Solutions. All rights reserved

  • Privacy Policy
  • Terms & Conditions
  • Contact Us